US Patent 9944619 Compounds for the treatment of HIV
Patent 9944619 was granted and assigned to Gilead Sciences on April, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 3, 2017
Date of Patent
April 17, 2018
Patent Applicant
Patent Application Number
15357290
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9944619 Compounds for the treatment of HIV
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.